Skip to content
  • Instagram
logo The Onco Doc

Oncology, Reinvented for Tomorrow

Get Newsletter
  • Home
  • Blogs
  • Authors
Home » Archives for OncoDoc
About OncoDoc
The Oncodoc team is a group of passionate healthcare and marketing professionals dedicated to delivering accurate, engaging, and impactful content. With expertise across medical research, digital strategy, and clinical communication, the team focuses on empowering healthcare professionals and patients alike. Through evidence-based insights and innovative storytelling, Hidoc aims to bridge the gap between medicine and digital engagement, promoting wellness and informed decision-making.
Are You Losing Doctors’ Attention? Re-Engage with AI in Oncology Marketing
Posted inPharma Marketing

Are You Losing Doctors’ Attention? Re-Engage with AI in Oncology Marketing

Posted by OncoDoc September 2, 2025
Abstract The oncology landscape in the US is rapidly evolving, marked by scientific breakthroughs, an…
Read More
From Lab to Launch: Accelerating Oncology Drug Commercialization with AI-Driven Insights
Posted inPharma Marketing

From Lab to Launch: Accelerating Oncology Drug Commercialization with AI-Driven Insights

Posted by OncoDoc September 2, 2025
Introduction: The AI-Powered Future of Oncology Commercialization The journey of an oncology drug from discovery…
Read More
The New Era of Precision Engagement: AI’s Transformative Role in Oncology Pharma Marketing in 2025
Posted inPharma Marketing

The New Era of Precision Engagement: AI’s Transformative Role in Oncology Pharma Marketing in 2025

Posted by OncoDoc September 2, 2025
Introduction: Precision Marketing at a Tipping Point Oncology pharma marketing has entered a defining moment…
Read More
Why 70% of Oncology Drug Launches Falter? How AI-Powered Digital Marketing Platforms, like Hidoc, are Rewriting the Rules for US Pharma
Posted inPharma Marketing

Why 70% of Oncology Drug Launches Falter? How AI-Powered Digital Marketing Platforms, like Hidoc, are Rewriting the Rules for US Pharma

Posted by OncoDoc September 1, 2025
Abstract  The oncology drug development landscape is notoriously challenging, with a staggering 70% of new…
Read More
AI-Driven Patient Journey Mapping in Oncology: Precision Marketing for a Patient-First Future
Posted inPharma Marketing

AI-Driven Patient Journey Mapping in Oncology: Precision Marketing for a Patient-First Future

Posted by OncoDoc September 1, 2025
Introduction: The Power of Real-Time Patient Journey Mapping The oncology patient journey is no longer…
Read More
The Human’s Role: The Final Arbiter and Strategic Thinker in Oncology Pharma Marketing
Posted inPharma Marketing

The Human’s Role: The Final Arbiter and Strategic Thinker in Oncology Pharma Marketing

Posted by OncoDoc September 1, 2025
Introduction: AI-Driven Innovation, Human-Centered Oversight The oncology pharma marketing landscape is evolving rapidly, driven by…
Read More
Beyond the Scroll: Can Unnati Drive Unprecedented Oncology Awareness for US Pharma?
Posted inPharma Marketing

Beyond the Scroll: Can Unnati Drive Unprecedented Oncology Awareness for US Pharma?

Posted by OncoDoc August 30, 2025
Abstract In the complex and rapidly evolving US oncology market, driving effective awareness among Healthcare…
Read More
Bridging Science and Stories: Pharma Marketing in Oncology 2025
Posted inPharma Marketing

Bridging Science and Stories: Pharma Marketing in Oncology 2025

Posted by OncoDoc August 30, 2025
Introduction: Marketing With Meaning in Modern Oncology Oncology is a field where time, trust, and…
Read More
Cancer Care Conversations 2025: Pharma Marketing That Builds Trust and Transforms Outcomes
Posted inPharma Marketing

Cancer Care Conversations 2025: Pharma Marketing That Builds Trust and Transforms Outcomes

Posted by OncoDoc August 30, 2025
Introduction: A Human-Centered Shift in Oncology Marketing In 2025, oncology marketing is no longer about…
Read More
24/7 Engagement in Oncology: Can Pharma Brands Afford to Ignore MediBot?
Posted inPharma Marketing

24/7 Engagement in Oncology: Can Pharma Brands Afford to Ignore MediBot?

Posted by OncoDoc August 29, 2025
Abstract The modern oncology landscape is characterized by a relentless influx of complex scientific data…
Read More

Posts pagination

1 2 3 … 21 Next page

Stay informed. Stay ahead.
Get the latest oncology
insights and pharma
marketing trends delivered
straight to your inbox.
Subscribe to our Newsletter!

India: Infedis Infotech LLP.
1st Floor, Office No 108, S No 557 A 1 CTS No
97, Suyog Center, Gultekdi, Pune, Maharashtra
For Queries/Grievances, Contact : V. Gadia
+91-9665017922
info@hidoc.co
LLP Identification Number : AAH-8647

Infedis Health Private Limited.
Suyog Center, Office No. 108, 1st Floor, Gultekdi, Pune, Maharashtra, India - 411037
CIN of the Company : U74999PN2018PTC175141

US : Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
+1 (415) 463-3094

CSR Policy

Copyright 2025 â€” The Onco Doc. All rights reserved.
Terms & Conditions - LLP |  Inc. |  Privacy Policy - LLP |  Inc. |  Account Deactivation
Scroll to Top